𝔖 Bobbio Scriptorium
✦   LIBER   ✦

OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer

✍ Scribed by Maria Gazouli; Maria G. Roubelakis; George E. Theodoropoulos; Joanna Papailiou; Anna Vaiopoulou; Kalliopi I. Pappa; Nikolaos Nikiteas; Nicholas P. Anagnou

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
255 KB
Volume
51
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

OCT4, a POU‐domain transcription factor is considered to be a key factor in maintaining the pluripotency of stem cells. Several OCT4 isoforms are differentially expressed in human pluripotent and non‐pluripotent cells. Reactivation of OCT4 expression is postulated to occur in differentiated cells that have undergone tumorigenesis. To examine OCT4 expression in colorectal cancer (CRC) tissues, and to assess the efficacy of OCT4 as a potential biomarker for CRC, in this study, we investigated its expression in CRC tissues, evaluated its relationship to various clinicopathological parameters and defined the isoform of OCT4 that was found to be expressed in CRC cases. Primary tumor tissues and matching adjacent non‐cancerous tissues were obtained from 84 CRC patients. OCT4 expression and isoform determination were documented by reverse transcription‐PCR and real‐time PCR. OCT4, Sox‐2, and NANOG localization were performed using immunohistochemistry. The isoforms expressed in the studied cases were confirmed by sequencing. Twenty biopsy specimens representing healthy tissues, retrieved from colonoscopy were studied in parallel as controls. OCT4 expression levels were higher in CRC tissues compared to matching, adjacent non‐cancerous tissues, and healthy controls. Additionally, the levels of OCT4 expression in CRC tissues correlated with tumor stage. OCT4 and Sox‐2 were localized in the nuclei and the cytoplasm of CRC cells. In all CRC cases, we found that the OCT4B1 isoform is expressed. Over‐expression of OCT4B1 was found in poorly and moderately differentiated CRC tissues. In conclusion, the data imply that OCT4B1 isoform may represent a potential biomarker for the initiation, progression, and differentiation of CRC. Mol. Carcinog. © 2011 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

OCT-4, an embryonic stem cell marker, is
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer
✍ Yaser Atlasi; Seyed J. Mowla; Seyed A.M. Ziaee; Ahmad-Reza Bahrami 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB 👁 1 views

## Abstract __OCT‐4__ (also known as __POU5F1__) is a key regulator of self‐renewal in embryonic stem cells. Regarding the new cancer stem cell concept, the expression of such genes is potentially correlated with tumorigenesis and can affect some aspects of tumor behavior, such as tumor recurrence

Oct-4, Rex-1, and Gata-4 expression in h
Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression
✍ Stéphane Roche; Marie-Jeanne Richard; Marie-Christine Favrot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

## Abstract Micro‐environment seems to exert an important influence on human mesenchymal stem cell (MSC) differentiation and proliferative capacity in bone marrow as well as in culture ex vivo. Oct‐4, Rex‐1, and TERT genes are well‐known for the maintenance of pluripotentiality differentiation and

Expression profiling of MMA-1a and splic
Expression profiling of MMA-1a and splice variant MMA-1b: New cancer/testis antigens identified in human melanoma
✍ Nicole J.W. de Wit; Ulrich H. Weidle; Dirk J. Ruiter; Goos N.P. van Muijen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 207 KB 👁 2 views

## Abstract Using high‐density oligonucleotide array analysis, we have recently compared the gene expression profiles of 2 human melanoma cell lines with marked difference in metastatic behavior after subcutaneous inoculation into nude mice (de Wit __et al__., Melanoma Res, in press). We identified

Cyclin D1b variant promotes cell invasiv
Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells
✍ Chul Jang Kim; Kayoko Nishi; Takahiro Isono; Yusuke Okuyama; Yukihiro Tambe; Yus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

## Abstract Alternative splicing in the __cyclin D1__ gene produces __cyclin D1b__ variant which lacks a C‐terminal region containing the threonine‐286 (T286) phosphorylation site required for nuclear export. We have shown that the expression of the __cyclin D1b__ variant is detected in about 60% o

PDGF B mRNA variants in human tumors wit
PDGF B mRNA variants in human tumors with similarity to the v-sis oncogene: Expression of cellular PDGF B protein is associated with exon 1 divergence, but not with a 3'UTR splice variant
✍ Susanne Heller; Lena Scheibenpflug; Bengt Westermark; Monica Nistér 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 418 KB 👁 2 views

While platelet-derived growth factor, PDGF, is not regularly expressed in mesenchymal tissues, PDGF B mRNA is often found in tumors derived from these tissues. PDGF B protein is also present, but the protein levels in individual tumors do not appear to correlate well with those of the mRNA. PDGF B i

Loss of programmed cell death 4 expressi
Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer
✍ Giridhar Mudduluru; Fabian Medved; Rainer Grobholz; Camela Jost; Anette Gruber; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB 👁 1 views

## Abstract ## BACKGROUND. Programmed cell death 4 (Pdcd4) inhibits malignant transformation, and initial studies of Pdcd4 suggested the regulation of Pdcd4 localization by protein kinase B (Akt). However, supporting patient tissue data are missing, and the diagnostic/prognostic potential of Pdcd4